China Resources Pharmaceutical Group Limited (3320.HK)
HKD 4.9
(0.0%)
HKD 4.9
(0.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 85.84 Billion HKD | 28.14% |
| 2022 | 66.99 Billion HKD | -18.88% |
| 2021 | 82.58 Billion HKD | 40.85% |
| 2020 | 58.63 Billion HKD | 7.54% |
| 2019 | 54.52 Billion HKD | -13.75% |
| 2018 | 63.21 Billion HKD | 29.66% |
| 2017 | 48.75 Billion HKD | 22.42% |
| 2016 | 39.82 Billion HKD | -16.4% |
| 2015 | 47.64 Billion HKD | 27.85% |
| 2014 | 37.26 Billion HKD | 19.37% |
| 2013 | 31.21 Billion HKD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 97.3 Billion HKD | 0.0% |
| 2023 FY | 85.84 Billion HKD | 28.14% |
| 2023 Q4 | 62.16 Billion HKD | 0.0% |
| 2023 Q2 | 90.71 Billion HKD | 0.0% |
| 2022 FY | 66.99 Billion HKD | -18.88% |
| 2022 Q2 | 89.56 Billion HKD | 0.0% |
| 2022 Q4 | 66.99 Billion HKD | 0.0% |
| 2021 Q4 | 82.58 Billion HKD | 0.0% |
| 2021 Q2 | 81.56 Billion HKD | 0.0% |
| 2021 FY | 82.58 Billion HKD | 40.85% |
| 2020 Q4 | 58.63 Billion HKD | 0.0% |
| 2020 Q2 | 72.25 Billion HKD | 0.0% |
| 2020 FY | 58.63 Billion HKD | 7.54% |
| 2019 Q4 | 54.52 Billion HKD | 0.0% |
| 2019 FY | 54.52 Billion HKD | -13.75% |
| 2019 Q2 | 74.5 Billion HKD | 0.0% |
| 2018 FY | 63.21 Billion HKD | 29.66% |
| 2018 Q4 | 50.93 Billion HKD | 0.0% |
| 2018 Q2 | 45.3 Billion HKD | 0.0% |
| 2017 Q4 | 36.87 Billion HKD | 0.0% |
| 2017 FY | 48.75 Billion HKD | 22.42% |
| 2017 Q2 | 36.14 Billion HKD | 0.0% |
| 2016 Q2 | 37.72 Billion HKD | 0.0% |
| 2016 Q4 | 25.71 Billion HKD | 0.0% |
| 2016 FY | 39.82 Billion HKD | -16.4% |
| 2015 FY | 47.64 Billion HKD | 27.85% |
| 2015 Q4 | 37.21 Billion HKD | 0.0% |
| 2014 FY | 37.26 Billion HKD | 19.37% |
| 2013 FY | 31.21 Billion HKD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 6.8 Million HKD | -1260509.656% |
| Grand Pharmaceutical Group Limited | 3.4 Billion HKD | -2421.783% |
| Extrawell Pharmaceutical Holdings Limited | 120.41 Million HKD | -71195.993% |
| Wai Yuen Tong Medicine Holdings Limited | 460.94 Million HKD | -18524.079% |
| Qianhai Health Holdings Limited | 487 Thousand HKD | -17627724.435% |
| Lee's Pharmaceutical Holdings Limited | 204.14 Million HKD | -41953.25% |
| Essex Bio-Technology Limited | 294.02 Million HKD | -29097.625% |
| Tongfang Kontafarma Holdings Limited | 333.82 Million HKD | -25616.474% |
| PuraPharm Corporation Limited | 424.77 Million HKD | -20110.35% |
| SSY Group Limited | 3.37 Billion HKD | -2444.317% |
| JBM (Healthcare) Limited | 133.4 Million HKD | -64250.075% |
| Jacobson Pharma Corporation Limited | 749.37 Million HKD | -11355.819% |